Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
| 02/28/2018 | 11/30/2017 | 08/31/2017 | 05/31/2017 | 02/28/2017 | |
|---|---|---|---|---|---|
| Net Income | 8.49% | 76.66% | -145.33% | 38.57% | 93.06% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -18.05% | 197.72% | -310.13% | -25.00% | -- |
| Total Other Non-Cash Items | -22.73% | -85.67% | 190.07% | -65.17% | -90.05% |
| Change in Net Operating Assets | -114.67% | -97.93% | 584.91% | 107.67% | -194.94% |
| Cash from Operations | -35.53% | -204.90% | 221.86% | 40.22% | 14.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00% | 344.12% | -144.78% | -3.74% | -39.02% |
| Total Debt Repaid | -26.67% | -200.00% | 83.22% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.33% | 299.00% | -164.35% | -26.97% | -39.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46,600.00% | -99.81% | 54,000.00% | 99.65% | -202.88% |
